Update on Zhejiang Shapuaisi's bendazac lysine eye drops issue
Zhejiang Shapuaisi Pharmaceutical Co., Ltd. (Zhejiang Shapuaisi) announced on 16 Dec., 2017 that it had suspended ad issuing on 12 Dec., and its stock would resume trading on 18 Dec.On 7 Dec., the company applied for trading suspension urgently after...
Amino Acids China E-News 201712